Financial Disclosure Statement

MSACL 2018 US Abstract Title:
Feasibility of Mitra® Microsampling Devices in Remote, Longitudinal Monitoring of Apolipoprotein B/ApolipoProtein A-I in Patients at Risk for Cardiac Events
Kelly Mouapi
Cedars Sinai Medical Center

DescriptionY/NSource
Grantsno
Salaryno
Board Memberno
Stockno
Expensesno

IP Royalty: no

Planning to mention or discuss specific products or technology of the company(ies) listed above:

yes